Salem Radio Network News Thursday, October 21, 2021


AstraZeneca to invest $360 million in new Irish drug manufacturing site

(Reuters) – AstraZeneca said on Tuesday it would invest $360 million to develop an advanced manufacturing facility in Ireland to produce primary ingredients for medicines.

The Anglo-Swedish drugmaker, which completed its $39 billion purchase of rare disease drugs maker Alexion in July, has a large portfolio of treatments for cancer, heart disease, diabetes and a COVID-19 vaccine, with several drugs under trials.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Arun Koyyur)


Editorial Cartoons

View More »

Michael Ramirez
Thu, Oct 14, 2021